ASCEND BY NTHRYS
Research Abroad Products

Gene Fusion Project Topics

Browse all focused areas across all project categories under this field.

Showing 97–108 of 200 project topics
Precision Oncology Matchmaking Service Using Fusion Data
A B2B2C platform connecting patients with fusion-driven cancers to targeted clinical trials and precision medicines using real-time fusion profiling data. Monetizes through patient enrollment fees from trial sponsors, licensing to hospital networks, and value-added clinical advisory services.
Cancer Gene Fusion Analytics Platform Dev Click to view more details →
Next-Generation Sequencing Bioinformatics Pipeline SaaS
A turnkey bioinformatics pipeline SaaS that processes raw NGS data, detects fusion events, and delivers structured results via API and web portal for integration into existing lab systems. Creates recurring revenue through per-sample processing fees and eliminates expensive on-premise infrastructure costs for diagnostic partners.
Cancer Gene Fusion Analytics Platform Dev Click to view more details →
Liquid Biopsy Fusion Detection Kit and Analytics Platform
A commercial liquid biopsy product combining proprietary capture reagents with cloud-based fusion analytics for detecting circulating tumor-derived fusion DNA from blood samples. Captures high-margin revenue through consumable sales, laboratory services, and recurring software licensing to clinical and research institutions.
Cancer Gene Fusion Analytics Platform Dev Click to view more details →
Fusion Variant Assessment and Evidence Curation Software
An enterprise software tool that aggregates clinical evidence, literature, and functional assays for cancer gene fusions to enable confident therapeutic recommendations and variant classification. Commands premium pricing by serving as the definitive fusion intelligence layer for precision oncology networks, tumor boards, and molecular pathology centers.
Cancer Gene Fusion Analytics Platform Dev Click to view more details →
Real-time Gene Fusion Detection SaaS Platform
A cloud-based SaaS platform that processes liquid biopsy samples to identify and quantify gene fusion events within hours using proprietary algorithms and machine learning models. Enables oncology labs and diagnostic centers to monetize fusion testing through subscription licensing, per-sample fees, and premium tier analytics starting at $50K-$500K annually.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Automated Liquid Biopsy Fusion Analysis Workflow Software
Enterprise workflow automation software that integrates sample preparation, sequencing, and bioinformatics analysis for gene fusion detection from circulating tumor DNA and RNA. Generates recurring revenue through software licenses, implementation services, and ongoing technical support contracts worth $200K-$2M per customer annually.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Multi-Cancer Gene Fusion Screening Commercial Kit
Proprietary liquid biopsy test kit that simultaneously screens for 100+ pathogenic gene fusions across multiple cancer types from a single blood draw. Achieves clinical lab certification and captures per-sample revenue of $1,500-$3,500 with high-volume potential through hospital and diagnostic lab distribution channels.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
AI-Powered Fusion Variant Classification and Reporting Engine
Commercial AI software that classifies gene fusion variants by pathogenicity, druggability, and clinical relevance, then auto-generates clinician-ready reports with treatment recommendations. Monetizes through API licensing to sequencing labs, white-label integration fees of $100K-$500K per partner, and per-report transaction fees.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Liquid Biopsy Fusion Biomarker Discovery Platform
Research-grade SaaS platform enabling pharmaceutical and biotech companies to discover novel gene fusion biomarkers associated with drug response and disease progression. Generates revenue through research collaboration agreements, licensing deals with biopharma companies, and data partnerships worth $500K-$5M per contract.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Clinical Grade Gene Fusion Profiling Laboratory Service
CLIA-certified and CAP-accredited laboratory service offering comprehensive gene fusion profiling from patient liquid biopsies with rapid turnaround times. Builds a high-margin diagnostic services business model generating $2,000-$5,000 per patient test with potential for 1,000+ tests monthly at scale.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Portable Bedside Gene Fusion Micro-Diagnostic Device
Miniaturized, point-of-care diagnostic device enabling rapid gene fusion detection at patient bedside without centralized lab infrastructure. Commercialized as hardware-as-a-service or subscription model capturing $500-$2,000 per device monthly rental plus consumables revenue of $10M+ addressable market.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Fusion Gene Database and Clinical Interpretation API Service
Commercial API service delivering curated gene fusion annotations, clinical evidence, drug targets, and trial matching for integration into existing laboratory information systems. Monetizes through tiered API pricing, per-query fees, and enterprise contracts with diagnostic networks generating $100K-$1M annual recurring revenue.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →